This is particularly relevant because bupropion carries an FDA boxed warning regarding seizure risk, and seizure threshold is lowered by several modifiable factors: abrupt alcohol or benzodiazepine discontinuation, eating disorders (anorexia nervosa, bulimia), electrolyte abnormalities, and conditions that cause metabolic disruption [2]
Semaglutide medications are approved for the treatment of type 2 diabetes as an accompaniment to diet and exercise, typically as once-weekly injections or once-daily oral drugs
developed a smart nanoparticle (TQCN) generated from quercetin and modified with triphenylphosphine for treatment of AD targeting ferroptosis
, , , , 20
BPC-157 accelerates the healing of ligaments, tendons, and muscle, especially at sites of mechanical stress (Sikiric et al., Journal of Physiology)
Reddys Semaglutide Injection Both are approved for the once-weekly treatment of adults with type 2 diabetes to improve blood sugar control